These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Author: Kurmukov AG, Aĭzikov MI, Rasulova SA, Makhmudov OKh.
    Journal: Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147.
    Abstract:
    Amorphin--24-vicyanoside (C34H4O16(2)H2O)--in a dose of 10 mg/kg orally decreases the content of cholesterol, total lipids, atherogenic lipoproteids in the blood and organs of intact rats and rats with endogenous or ethanol hyperlipemia, inhibits the development of experimental atherosclerosis in rabbits induced by the combination of risk factors (cholesterol + glucose + hypodynamia), decreases the content of lipids in the blood and organs (especially in aorta), prevents the development of morphological manifestations of the aorta atherosclerosis.
    [Abstract] [Full Text] [Related] [New Search]